Literature DB >> 16563230

The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment.

Elisabeth A Seftor1, P S Meltzer, D A Kirschmann, N V Margaryan, R E B Seftor, Mary J C Hendrix.   

Abstract

A dynamic, complex relationship exists between tumor cells and their microenvironment, which plays a pivotal role in cancer progression, yet remains poorly understood. Particularly perplexing is the finding that aggressive melanoma cells express genes associated with multiple cellular phenotypes, in addition to their ability to form vasculogenic-like networks in three-dimensional matrix--called vasculogenic mimicry, which is illustrative of tumor cell plasticity. This study addressed the unique epigenetic effect of the microenvironment of aggressive melanoma cells on the behavior of poorly aggressive melanoma cells exposed to it. The data show significant changes in the global gene expression of the cells exposed to 3-D matrices preconditioned by aggressive melanoma cells, including the acquisition of a vasculogenic cell phenotype, upregulation of ECM remodeling genes, and increased invasive ability--indicative of an epigenetic, microenvironment-induced reprogramming of poorly aggressive melanoma cells. However, this epigenetic effect was completely abrogated when a highly cross-linked collagen matrix was used, which could not be remodeled by the aggressive melanoma cells. These findings offer an unique perspective of the inductive properties associated with an aggressive melanoma microenvironment that might provide new insights into the epigenetic regulation of tumor cell plasticity and differentiation, as well as mechanisms that could be targeted for novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563230      PMCID: PMC3933110          DOI: 10.1111/j.1582-4934.2006.tb00299.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  116 in total

1.  Transformation of fibroblasts into endothelial cells during angiogenesis.

Authors:  K Kon; T Fujiwara
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

2.  Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.

Authors:  Matthew V Sheffield; Herman Yee; Christine C Dorvault; Katherine N Weilbaecher; Isam A Eltoum; Gene P Siegal; David E Fisher; David C Chhieng
Journal:  Am J Clin Pathol       Date:  2002-12       Impact factor: 2.493

Review 3.  Fibronectin and its integrin receptors in cancer.

Authors:  E Ruoslahti
Journal:  Adv Cancer Res       Date:  1999       Impact factor: 6.242

4.  Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit.

Authors:  S L Mellor; M Cranfield; R Ries; J Pedersen; B Cancilla; D de Kretser; N P Groome; A J Mason; G P Risbridger
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

5.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

6.  Cloning and expression of the tumor-associated antigen L6.

Authors:  J S Marken; G L Schieven; I Hellström; K E Hellström; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Embryonic expression of epithelial membrane protein 1 in early neurons.

Authors:  P Wulf; U Suter
Journal:  Brain Res Dev Brain Res       Date:  1999-09-06

Review 8.  Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets.

Authors:  D Grossman; D C Altieri
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

9.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

10.  Molecular determinants of human uveal melanoma invasion and metastasis.

Authors:  Elisabeth A Seftor; Paul S Meltzer; Dawn A Kirschmann; Jacob Pe'er; Andrew J Maniotis; Jeffrey M Trent; Robert Folberg; Mary J C Hendrix
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more
  14 in total

1.  Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma.

Authors:  Rosa Bosch; María José Moreno; Rebeca Dieguez-Gonzalez; María Virtudes Céspedes; Alberto Gallardo; Josep Nomdedeu; Miguel Angel Pavón; Iñigo Espinosa; Maria Antònia Mangues; Jorge Sierra; Isolda Casanova; Ramon Mangues
Journal:  Clin Exp Metastasis       Date:  2012-01-20       Impact factor: 5.150

2.  Endoglin suppresses human prostate cancer metastasis.

Authors:  Minalini Lakshman; Xiaoke Huang; Vijayalakshmi Ananthanarayanan; Borko Jovanovic; Yueqin Liu; Clarissa S Craft; Diana Romero; Calvin P H Vary; Raymond C Bergan
Journal:  Clin Exp Metastasis       Date:  2010-10-28       Impact factor: 5.150

3.  Matrix-coated transwell-cultured TM4 sertoli cell testosterone-regulated gene expression mimics in vivo expression.

Authors:  Brianna C Prante; Kiera L Garman; Brandon N Sims; J Suzanne Lindsey
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-09-23       Impact factor: 2.416

Review 4.  [Relevance of cell culture models in cutaneous tumour biology: part II: complex culture systems].

Authors:  J Hatina; T Ruzicka
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

5.  Expression and distribution of MUC18 in human uveal melanoma.

Authors:  Kenneth Lai; Vidushi Sharma; Martine J Jager; R Max Conway; Michele C Madigan
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

Review 6.  Generation of erythroid cells from polyploid giant cancer cells: re-thinking about tumor blood supply.

Authors:  Zhigang Yang; Hong Yao; Fei Fei; Yuwei Li; Jie Qu; Chunyuan Li; Shiwu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-07       Impact factor: 4.553

7.  A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.

Authors:  Wei Sun; Yue Z Fan; Wen Z Zhang; Chun Y Ge
Journal:  J Exp Clin Cancer Res       Date:  2011-04-29

8.  MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.

Authors:  Mariusz L Hartman; Beata Talar; Anna Gajos-Michniewicz; Malgorzata Czyz
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

9.  Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.

Authors:  Camila Ferreira de Souza; Patrícia Xander; Ana Carolina Monteiro; Amanda Gonçalves dos Santos Silva; Débora Castanheira Pereira da Silva; Sabine Mai; Viviane Bernardo; José Daniel Lopes; Miriam Galvonas Jasiulionis
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

10.  Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.

Authors:  Orit Itzhaki; Eyal Greenberg; Bruria Shalmon; Adva Kubi; Avraham J Treves; Ronnie Shapira-Frommer; Camilla Avivi; Rona Ortenberg; Eytan Ben-Ami; Jacob Schachter; Michal J Besser; Gal Markel
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.